BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 30824727)

  • 1. Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer.
    Huang H; Liu Q; Zhu L; Zhang Y; Lu X; Wu Y; Liu L
    Sci Rep; 2019 Mar; 9(1):3284. PubMed ID: 30824727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
    Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
    World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
    Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
    Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer.
    Deng Q; Long Q; Liu Y; Yang Z; Du Y; Chen X
    BMC Cancer; 2021 Nov; 21(1):1282. PubMed ID: 34844568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
    Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
    Front Oncol; 2020; 10():341. PubMed ID: 32219070
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.
    Han X; Liu S; Yang G; Hosseinifard H; Imani S; Yang L; Maghsoudloo M; Fu S; Wen Q; Liu Q
    Gynecol Oncol; 2021 Jan; 160(1):351-360. PubMed ID: 33092868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma.
    Lv Y; Zhang S; Liu Z; Tian Y; Liang N; Zhang J
    Clin Neurol Neurosurg; 2019 Jun; 181():24-27. PubMed ID: 30974296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
    Yan X; Li G
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients.
    Shi H; Jiang Y; Cao H; Zhu H; Chen B; Ji W
    Dis Markers; 2018; 2018():1787424. PubMed ID: 30627220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients.
    Holub K; Biete A
    Clin Transl Oncol; 2019 Jul; 21(7):836-844. PubMed ID: 30470994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
    Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
    Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
    Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
    Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of systemic immune-inflammation index in patients with gastric cancer.
    Wang K; Diao F; Ye Z; Zhang X; Zhai E; Ren H; Li T; Wu H; He Y; Cai S; Chen J
    Chin J Cancer; 2017 Sep; 36(1):75. PubMed ID: 28899420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.
    Huang Y; Chen Y; Zhu Y; Wu Q; Yao C; Xia H; Li C
    Front Surg; 2021; 8():704235. PubMed ID: 34746222
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
    Matsubara S; Mabuchi S; Takeda Y; Kawahara N; Kobayashi H
    PLoS One; 2021; 16(5):e0248871. PubMed ID: 33989285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis.
    Geng Y; Shao Y; Zhu D; Zheng X; Zhou Q; Zhou W; Ni X; Wu C; Jiang J
    Sci Rep; 2016 Dec; 6():39482. PubMed ID: 28000729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.